DRW Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
DRW Securities's MRNA Position: Q3 2026 in Review
DRW Securities opened a new position in Moderna (MRNA) in Q3 2026: 1,043 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: DRW Securities previously reported a position in MRNA as recently as Q4 2025.
DRW Securities first reported a position in MRNA in Q4 2020 and has held it in 6 quarters since. The position peaked at $276K in Q4 2021. 1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- DRW Securities held 1,043 shares of Moderna worth $201K as of Q3 2026.
- Moderna was a new DRW Securities position in Q3 2026.
- Moderna made up ﹤0.01% of DRW Securities's portfolio in Q3 2026, its #773 holding.
- DRW Securities first reported a position in Moderna in Q4 2020 and has held it in 6 quarters since.
- DRW Securities's Moderna position peaked at $276K in Q4 2021.
- 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on DRW Securities's 13F filing for Q3 2026, filed 13 Nov 2026.